Abiomed (ABMD) develops, manufactures and markets products heart devices including pumps. The company's product portfolio includes the Impella heart pumps and SmartAssist technology. The company has been on my watch-list as an investment opportunity since Oct 12 2019 after it reported issues on the pumps it manufactures for the left side of the heart. The stocks dipped. Such news is not abnormal for companies which develop products using cutting edge technologies. Normally, after some “clarification” by the company, the stock prices tend to go up. However, this was not the case for Abiomed